Roundtable: How AMR Threatens Cancer Care

Uncovering the overlooked danger of antimicrobial resistance in oncology treatment pathways

25 June 2025 | 15:00–15:45 CEST / 09:00–09:45 EST | Online | Free of charge | Registration required

About the online roundtable

Antimicrobial resistance (AMR) is an escalating global health threat—yet its devastating impact on cancer care remains under recognized. Cancer patients are uniquely vulnerable to infections due to immunosuppression from chemotherapy and other treatments. As resistance to life-saving antibiotics grows, so does the risk of complications, treatment delays, and mortality in oncology.

This 45-minute online roundtable organized by the AMR Insights Ambassador Network brings together leading experts to explore the critical intersection of AMR and cancer care. Drawing on recent high-impact studies, we will discuss the scale and consequences of AMR in both inpatient and outpatient oncology settings—and what must be done to address this urgent threat.

Moderator & Speakers

• Moderator: Diane Flayhart, Antimicrobial Resistance Fighter Coalition / BD, USA, and author of the two of featured publications

• Panelists:

  • Dr. Vikas Gupta PharmD, FIDSA – Sr Director, Q-linea, USA, and lead author of the two of featured publications

  • Dr. Afreenish Amir – Project Director AMR, NIH Pakistan

  • Dr. Margaret Lubwama – Clinical Microbiologist, Makerere University, Uganda

  • Prof. Debbie Goff – ID specialist, Ohio State University Wexner Medical Center, USA

Based on Key Publications

• Gupta et al. (2024) – Burden of AMR in hospitalized cancer patients (Cancer Medicine)

• Gupta et al. (2025) – AMR in US outpatients with cancer (Lancet Oncology)

• Sallah et al. (2025) – Scoping review of AMR in hematologic malignancies (Lancet Oncology)

• Shropshire & Shelburne (2025) – Editorial on AMR across cancer care (Lancet Oncology)

Roundtable Objectives

• Review Key Research Findings: Understand the burden of AMR in oncology patients across care settings

• Explore Clinical and Research Implications: Discuss how AMR impacts cancer care and identify priorities for prevention and innovation

• Raise Awareness Across Sectors: Highlight the urgency of this issue for health professionals, researchers, NGOs, authorities, and the wider public

Who Should Attend?

This webinar is designed for:

• Oncologists and clinicians in cancer care

• Health professionals, infection specialists, and pharmacists

• Patients, advocates, and all those interested in improving cancer outcomes

• Representatives from NGOs, authorities, and health agencies

Free Registration Required

Participation is free, but registration is required:

Back